Advertisement

Improvement of Psoriasis with Oral Nystatin

  • Ö Aşçioǧlu
  • Ü Soyuer
  • E. Aktaş
Part of the Federation of European Microbiological Societies Symposium Series book series (FEMS, volume 50)

Abstract

Psoriasis may result from the interaction of yeasts and other microorganisms with an abnormally responsive alternative complement pathway 1–3. Meanwhile, we observed a significantly increased yeast colonization of gut of psoriatic patients 4.

Keywords

Placebo Group Hair Root Psoriasis Patient Double Blind Placebo Severe Psoriasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E.W. Rosenberg and P.W. Belew, Microbial factors in psoriasis,Arch. Dermatol., 118: 143 (1982).PubMedCrossRefGoogle Scholar
  2. 2.
    N. Crutcher, E.W. Rosenberg et al., Oral nystatin in the treatment of psoriasis,Arch. Dermatol., 120: 435 (1984).PubMedCrossRefGoogle Scholar
  3. 3.
    E.W. Rosenberg and P.W. Belew, Improvement of psoriasis of the scalp with ketoconazole,Arch. Dermatol., 118: 370 (1982).PubMedCrossRefGoogle Scholar
  4. 4.
    Ü. Soyuer, Ö. Asçioglu, and E. Aktap, The pathogenetic role ofCandidain psoriasis, in:“FEMS-Symposium onCandidaand Candidamycosis-Abstracts”, p. 74, Bilgehan Publishing House, Izmir (1989).Google Scholar
  5. 5.
    T. Frediksson, and V. Petterson, Severe psoriasis oral therapy with a new retinoid,Dermatologica, 157: 238 (1978).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Ö Aşçioǧlu
    • 1
  • Ü Soyuer
    • 1
  • E. Aktaş
    • 1
  1. 1.Department of Dermatology, Faculty of MedicineErciyes UniversityKayseriTurkey

Personalised recommendations